Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2017-004852-52Phase 2Completed
Phase 2, single-arm trial of dronabinol, sponsored by Medical University of Vienna. Primary endpoint: Optic nerve head blood flow. Started Mar 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2017-004852-52.